Kezdőlap
Mélykutatási eredmények
QA
Jelek
Területek
Módszertan
Névjegy
Keresés
Kutatási jelek – Signal Engine
Lymphoma
— Diffuse large B-cell lymphoma
Case Study: 65-Year-Old with History of Waldenstrom Macroglobulinemia
— Waldenstrom macroglobulinemia
Acute Lymphoblastic Leukemia
— Acute lymphoblastic leukemia
Mantle Cell Lymphoma
— Mantle cell lymphoma
Radiopharmaceutical therapy delays metastatic prostate cancer disease progression when given earlier
— Prostate cancer
Cemiplimab Addition to Docetaxel and Ramucirumab Trial in NSCLC
— NSCLC
Esophageal Cancer
— Esophageal cancer
Esophageal Cancer
— Esophageal cancer
Thyroid Cancer
— Thyroid cancer
Pancreatic Cancer
— Pancreatic cancer
Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
— NSCLC
Anti‑tumor Activity of CBI‑1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI‑L Colorectal Cancer
— Colorectal cancer
Adagrasib Monotherapy and in Combination With Pembrolizumab for KRAS G12C‑Positive Non‑Small Cell Lung Cancer (NSCLC)
— NSCLC
Esophageal Cancer
— Esophageal cancer
Chronic Myeloid Leukemia
— Chronic myeloid leukemia
Stomach Cancer Clinical Trials at UCSF
— Gastric cancer
Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non‑Small Cell Lung Cancer
— NSCLC
Nasopharyngeal Cancer: Background, Relevant Anatomy, Pathogenesis
— Nasopharyngeal carcinoma
Treatment Strategies for B-Cell Acute Lymphoblastic Leukemia in Younger Patients
— Acute lymphoblastic leukemia
Understanding Modern Pleural Mesothelioma Treatments
— Malignant pleural mesothelioma
Előző
5/102
Következő